BMI View: Georgia will remain a marginal market for major drug firms, not least due to its modest
population size. Nevertheless, favourable business climate will continue to promote interest in the country's
pharmaceutical market. In the meantime, the small domestic industry will be supported by factors such as
international funding and government efforts to boost entrepreneurship.